This new market report contains data about Europe's drug delivery market for historic years 2014 & 2015. The base year of calculation is 2016 and the forecast period is 2017 to 2024.
- Advertising -
Europe Drug Delivery Market, By Route of Administration (Oral (Solid, Liquid, Semi-Solid), Injectable, Topical (Formulations, Transdermal Devices), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Centers, Others), By Distribution Channel (Direct Tenders, Hospital Pharmacies, Pharmacy Stores, Online Pharmacies), By Country (Germany, France, U.K., Spain, Italy, Russia, Netherlands, Switzerland, Turkey, Belgium, Rest of Europe) – Trends and Forecast to 2024
Europe drug delivery market is the second largest revenue pocket for the global drug delivery devices manufacturers with 29.9% market share in 2016. This market is expected to reach USD 536.1 billion by 2024 from USD 305.5 billion in 2016, at a CAGR of 7.3% in the forecast period 2017 to 2024.
Europe Drug Delivery Market – Market Segmentation:
The Europe pulmonary drug delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. The nebulizers are further sub segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers.
- Advertising -
he Europe ocular drug delivery is segmented into liquid ocular drugs, semi solid ocular drugs and ocular devices. Liquid ocular drug delivery includes eye drops and liquid sprays.
Semi solid ocular drug delivery includes gels and ointments. The ocular device includes drug coated lenses and ocular inserts.
The Europe Nasal drug delivery devices are segmented on the basis of product type into nasal drops, powders, gels, and sprays. The topical drug delivery segment is segmented on the basis of product form into liquid, semi-solid, solid and transdermal.
The transdermal topical drug delivery device includes transdermal patches and transdermal gels. The implantable drug delivery devices segment includes active and passive implantable drug delivery devices.
The transmucosal drug delivery segment is sub segmented into oral transmucosal and others. The oral transmucosal segment includes products such as buccal and sublingual drug delivery devices, while the others segment includes rectal transmucosal drug delivery and vaginal transmucosal drug delivery.
On the basis of end users the Europe drug delivery market is segmented into hospitals, over the counter, ambulatory surgery centers/clinics, home care settings, diagnostic centers, and others.
Browse Full Report with Details TOC @ http://databridgemarketresearch.com/reports/europe-drug-delivery-devices-market-trends-and-forecast-to-2024/
Based on geography the market is segmented into 11 countries:
- Rest of Europe
Some of the major players operating in this market are
- Bayer AG
- Johnson & Johnson
- Novartis AG
- Pfizer, Inc.
- F. Hoffmann-La Roche AG
- GlaxoSmithKline plc.
- Merck & Co.
- Antares Pharma
- Becton Dickinson and Company
- Biolase, Inc.
- Cima Labs, Inc.
- West Pharmaceuticals
- Antares Pharma
- Alkermes, Foamis
- Skyepharma AG
- Valeant Pharmaceuticals
- DSM Biomedical
- Catalent, Inc
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: